| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |